21st Jun 2022
Reddie & Grose is pleased to invite you to an online seminar which will guide you through the European Unitary Patent & Unified Patent Court (UPC). We will provide a detailed overview of the Unitary Patent system, including the UPC, and how the new system may affect your validation and litigation strategies. The Unitary Patent […]
21st Jun 2022
Reddie & Grose is pleased to invite you to an online seminar which will guide you through the European Unitary Patent & Unified Patent Court (UPC). We will provide a detailed overview of the Unitary Patent system, including the UPC, and how the new system may affect your validation and litigation strategies. The Unitary Patent […]
17th May 2022
The proposed European unitary patent system could come into force as early as this year, so it is important for patent owners to begin considering how they will make use of the new system, if at all. This article will explore some of the factors that organisations in the pharmaceutical sector should be considering in advance of the new system coming into effect.
11th Apr 2022
Being part of the UPC means that a common court is used for patent litigation in UPC member states, whereas opting out of the UPC means that the relevant national courts in those states are used for patent litigation instead. As discussed below, there are benefits to opting in or opting out of the UPC – but the actions of third parties could solidify the choice of whether rights are enforced and defended before the UPC or national courts.
7th Apr 2022
The Administrative Committee of the UPC have published documents confirming, as expected, that UK-based European Patent Attorneys can directly represent clients before the UPC.
28th Mar 2022
In the coming year, those applying for patents in Europe are expected to be presented with a new opportunity. Since its formation in 1977, the European Patent Office (EPO) has acted as a central examining and granting authority; it provides a single portal to apply for patent protection in 38 member countries, and, if a patent is granted, the opportunity to then validate this protection as a bundle of national patent rights in each member country where protection is desired. These validated patents must then be renewed, enforced, and revoked at a national level.
23rd Mar 2022
Previously we discussed the ongoing developments to bring the Unified Patent Court (UPC) and Unitary Patent into effect. However, one piece of the puzzle that has not yet been solved is how Supplementary Protection Certificates (SPCs), which are national intellectual property rights that can extend patent protection for pharmaceutical and plant protection products for up to five years, will be provided for under the new Unified Patent system.
1st Feb 2022
The EPO recently announced that they would be introducing two new transitional mechanisms that will assist applicants during the early uptake phase of the Unitary Patent.